A Retrospective Cohort Study for Main Postoperative Complications After SARS-CoV-2 Infection
- Conditions
- Gynecologic DiseaseIntestines CancerLiver CancerTraumaFractures, BonePulmonary Cancer
- Registration Number
- NCT05781581
- Lead Sponsor
- RenJi Hospital
- Brief Summary
To explore the relationship between SARS-CoV-2 infection in different time before operation and postoperative main complications (mortality, main pulmonary and cardiovascular complications) 30 days after operation; To determine the best timing of surgery after SARS-CoV-2 infection.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 50000
- Age≥18 years;
- Patients undergoing any type of surgery in operating room.
- Surgery under local anesthesia (without participation of anesthetist)
- Surgery outside the operating room, such as gastrointestinal endoscopy, puncture biopsy, etc
- Patients who cannot determine whether they have had SARS CoV-2 infection before surgery.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method All-cause mortality at 30 days after operation 30 days after surgery All-cause mortality at 30 days after operation
- Secondary Outcome Measures
Name Time Method Main pulmonary complications at 30 days after operation 30 days after surgery a composite of postoperative pneumonia, acute respiratory distress syndrome (ARDS) and unexpected ventilation
Major Adverse Cardiovascular Events (MACE) 30 days after surgery a composite of cardiogenic death, myocardial infarction, new-onset heart failure or cardiogenic shock, and cerebrovascular accident (CVA)